^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

anti-Claudin 18.2 CAR-T cell therapy

i
Associations
Trials
Company:
First Affiliated Hospital Xi'an Jiaotong University, Legend Biotech
Drug class:
CLDN18.2-targeted CAR-T immunotherapy
Associations
Trials